EUVIMEDEUVIMED entdecken
Crossref

International Patterns of Practice for SABR for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?

Salem Alfaifi, Alexander V Louie, Shankar Siva, Matthias Guckenberger, Gregory M M Videtic, Kristin A Higgins, Faiz Alshafa, Hamza AlGhamdi, Erin F Gillespie, Kevin Stephans, Layth Mula-Hussain, Stephen Harrow und 1 weitere

International Journal of Radiation Oncology*Biology*Physics · 2025

DOI: 10.1016/j.ijrobp.2025.04.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von Salem Alfaifi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio; Department of Radiation Oncology, King Faisal Medical City, Abha, Saudi Arabia. …. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Practice Patterns, Physicians', Radiosurgery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To generate an understanding of the similarities and variations in international practice patterns for SABR in early-stage non-small cell lung cancer. METHODS AND MATERIALS: An online survey was conducted from October to December 2023, addressing general clinical and technical considerations for lung SABR, and for 5 specific anatomic non-small cell lung cancer locations (peripheral, abutting chest wall, near brachial plexus, central, and ultracentral). Invitations to participate were extended through email and were distributed on social media. RESULTS: The survey was completed by 255 radiation oncologists, each representing a single institution across 51 countries. Respondents reported treating a median of 20 cases annually. A total of 38% of participants reported using single-fraction SABR, and 54% applied an upper limit on the maximum dose (Dmax). Among those who applied a Dmax limit, 58% reported a Dmax threshold at ≥130% of the prescription, though this limit varied by region and national economy status. Respondents from low- and middle-income countries were less likely to set a Dmax limit at ≥130% (30% vs 66%, P < .01) and less likely to use single-fraction SABR (14% vs 44%, P < .01). Higher annual SABR patient volumes were associated with higher Dmax adoption (г = 0.23, P < .01). Across the 5 clinical scenarios presented; 57 distinct dose regimens were recommended. The most common regimen in each scenario was: 54 Gy in 3 fractions for peripheral tumors, 50 Gy in 5 fractions for apical, central, and abutment of chest wall, and 60 Gy in 8 fractions for ultracentral tumors. Approximately two-thirds of practices recommend a biologically effective dose (BED10)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsPractice Patterns, Physicians'RadiosurgeryHumansSurveys and QuestionnairesRadiation OncologistsNeoplasm StagingMaleFemaleRadiotherapy DosageInternationality

Autor:innen und Institutionen

  • Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio; Department of Radiation Oncology, King Faisal Medical City, Abha, Saudi Arabia. Electronic address: ALFAIFS@ccf.org.
  • Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • Department of Radiation Oncology, Peter MacCallum Cancer Centre and the Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Radiation Oncology, University Hospital Zurich and the University of Zurich, Zurich, Switzerland.
  • Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio.
  • Department of Radiation Oncology, City of Hope Atlanta, Newnan, Georgia.

Zitieren

APA

Alfaifi, S., Louie, A. V., Siva, S., Guckenberger, M., Videtic, G. M. M., Higgins, K. A., Alshafa, F., AlGhamdi, H., Gillespie, E. F., Stephans, K., Mula-Hussain, L., Harrow, S., & Palma, D. A. (2025). International Patterns of Practice for SABR for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.04.022

Vancouver

Alfaifi S, Louie AV, Siva S, Guckenberger M, Videtic GMM, Higgins KA, et al. International Patterns of Practice for SABR for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2025.04.022

BibTeX
@article{Alfaifi2025,
  author = {Alfaifi, Salem and Louie, Alexander V and Siva, Shankar and Guckenberger, Matthias and Videtic, Gregory M M and Higgins, Kristin A and Alshafa, Faiz and AlGhamdi, Hamza and Gillespie, Erin F and Stephans, Kevin and Mula-Hussain, Layth and Harrow, Stephen and Palma, David A},
  title = {International Patterns of Practice for SABR for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2025},
  doi = {10.1016/j.ijrobp.2025.04.022}
}
Kostenlos starten →